Pharmaceuticals & Medicines Tenders

Description :SRPHC82281210-CORONARY DRUG ELUTING STENTS (1) SINGLE WIRE TECHNOLOGY ON COBALT BASED ALLOY PLATFORM (2) STENT WITH COATING OF BIOLINX POLYMER CARRIER FOR ACTIV E DRUG ZOTAROLIMUS SHOWN TO BE EFFECTIVE IN PREVENTING NEO-INTIMAL HYPERPLASIA) (3) STEN T DIAMETER SHOULD BE FROM 2.25 MM TO 4 MM AND LENGTH OF THE STENT FROM 12MM TO 38 MM. (4) THE STRUT THICKNESS SHOULD BE 81 MICRON OR LESS. (5) STENT DELIVERY SYSTEM SHOULD BE MONORAIL (SINGLE OPERATOR EXCHANGE OR RAPID EXCHANGE). (6) STENT SHOULD BE COMPATIBLE WITH 5FR GUIDING CATHETER (7) STENT DESIGN SHOULD BE OPEN CELL TYPE. (8) STENT SHOULD BE APPROVED BY DCGI. THE COPY OF DCGI APPROVAL SHOULD BE ENCLOSED IN THE TENDER BID. (9) FIV E YEARS LONG TERM EFFICACY AND SAFETY OF THE STENT IN TERMS OF TARGET VESSEL REVASCULARISATION (TVR) AND IN-SITU THROMBOSIS (IST) SHOULD BE DOCUMENTED / PUBLISHED IN PEER REVIEWED SCIENTIFIC JOURNALS.(10) THE DOCUMENTS PERTAINING TO THE EFFICACY AND SAFE TY OF THE STENT SHOULD BE ENCLOSED FOR THE BRAND THAT IS OFFERED IN THE TENDER BID (11) T HE MANUFACTURER/SUPPLIER SHOULD SUBMIT PROOF OF SUPPLY OF THE STENT TO A MAJOR GOVERN MENT INSTITUTE. [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitt ed: Max 8 lacs ] ] Consignee ACHD/Surg.Store/RH/PER, SR Tamil Nadu 114.00 Numbers

Description :SRPHC82281246-CORONARY DRUG ELUTING STENTS WITH (1) COBALT CHROMIUM ALLO Y AND WITH COATING OF POLYMER CARRIER FOR ACTIVE DRUG EVEROLIMUS. (2) CROSSING PROFILE L ESS THAN OR EQUAL TO 0.0425 INCH AND MID MARKER STENT PLACEMENT. (3) STENT DIAMETER SHO ULD BE FROM 2.0 MM TO 4 MM AND LENGTH OF THE STENT FROM 8 MM TO 38 MM. (4) THE STRUT THI CKNESS SHOULD BE 81 MICRON. (5) STENT DELIVERY SYSTEM SHOULD BE MONORAIL (SINGLE OPERAT OR EXCHANGE OR RAPID EXCHANGE). (6) STENT SHOULD BE COMPATIBLE WITH 5FR GUIDING CATHETER (7) STENT DESIGN SHOULD BE OPEN CELL TYPE. (8) STENT SHOULD BE APPROVED BY DCGI. THE COPY OF DCGI APPROVAL SHOULD BE ENCLOSED IN THE TENDER BID. (9) THE LONG TERM EFFICA CY AND SAFETY OF THE STENT IN TERMS OF TARGET VESSEL REVASCULARISATION (TVR) AND IN-SITU THROMBOSIS (IST) SHOULD BE DOCUMENTED / PUBLISHED IN PEER REVIEWED SCIENTIFIC JOURNALS.( 10) THE DOCUMENTS PERTAINING TO THE EFFICACY AND SAFETY OF THE STENT SHOULD BE ENCLOSE D IN THE TENDER BID (11) THE MANUFACTURER/SUPPLIER SHOULD SUBMIT PROOF OF SUPPLY OF THE STENT TO A MAJOR GOVERNMENT INSTITUTE. [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitt ed: Max 8 lacs ] ] Consignee ACHD/Surg.Store/RH/PER, SR Tamil Nadu 105.00 Numbers

Description :Drug Coated PTCA Balloon (Sirolimus). diamter minimum 1.5 mm to 4 mm with length 1